EXASbenzinga

Cancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual Guidance

Summary

Exact Sciences posted better-than-expected Q1 results and lifted its 2025 outlook, signaling confidence in growth and operational momentum.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 2, 2025 by benzinga